Quell Therapeutics is a cell therapy company
Quell Therapeutics has raised $156.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.
Quell Therapeutics's investors include Janus Henderson Investors, Point72, Jeito Capital, SV Health Investors, Fidelity.
Quell Therapeutics is headquartered in London, United Kingdom.
Quell Therapeutics is a cell therapy company
Quell Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Quell Therapeutics — Funding & Investors." VCBacked, November 29, 2021, https://www.vcbacked.co/company/quell-therapeutics. Accessed August 14, 2026.
VCBacked. (2021). Quell Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/quell-therapeutics
{{cite web |title=Quell Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/quell-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated